Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INVEST
NCT00133692Phase 4Completed
- Sponsor
- University of Florida
- Start
- Sep 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of verapamil and atenolol in hypertension (HTN) and coronary artery disease (CAD) (2 arms), sponsored by University of Florida. Primary endpoint: First occurrence of death or nonfatal myocardial infarction (MI) or nonfatal stroke at 2 years. Started Sep 1997; status: completed.
02
Drugs
verapamilatenolol
03
Conditions
hypertension (HTN)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00133692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133692.